Treatment Resistance

Cross-cancer resistance topics, progression patterns, and treatment-escape questions

This section gathers treatment-resistance topics that cut across cancer types, regimens, and biomarkers.

Use it when the question is about why treatment may stop working, not just what symptom it causes.

Start here

• Overview

• Dormant Cancer Cells

• Senescence — The Second Escape Route

• Drug Metabolism & Supplement Interactions

• TP53 in Cancer

Use this section for

• resistance mechanisms

• progression patterns

• pharmacokinetic and drug-exposure questions

• biomarker-driven treatment-escape logic

• dormancy, residual disease, and reactivation-risk questions

• therapy-induced senescence, SASP biology, and senolytic follow-up questions

• cross-cancer resistance pages that do not fit one disease hub

Related hubs elsewhere

• TP53 in Cancer in Testing, Monitoring & Biomarkers

• HER2CLIMB Resistance Mechanisms in Breast Cancer

Current status

This hub is still early.

It now has its own home anchor and overview so resistance topics can grow without being mixed into side-effect navigation.

This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.

© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.